MoneyWorks4Me

Zydus Lifesciences informs about disclosure

24 Apr 2024 Evaluate
Zydus Lifesciences has informed that the USFDA conducted an inspection at the Injectable Manufacturing site situated at Jarod, near Vadodara. The inspection was conducted from April 15 to April 23, 2024. The inspection closed with 10 observations. The Company will closely work with the USFDA to address and respond to the observations in an expeditious manner. 

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1737.00
Dr. Reddys Labs. 1236.95
Cipla 1324.90
Lupin 1940.25
Zydus Lifesciences 1117.20
View more..